JIHONG

[JIHONG @Jihong_Cui]

@Gritsman_lab @WenjunGuoLab @ScienceAdvances Thanks so much, Kira!

[JIHONG @Jihong_Cui]

@The_Ito_Lab @WenjunGuoLab @ScienceAdvances @Einstein_SCI @EinsteinCellBio Thank so much, Keisuke.

[JIHONG @Jihong_Cui]

@ShoTakeishi @WenjunGuoLab Thank you, Shoichiro!

[JIHONG @Jihong_Cui]

I am thrilled to share our latest article on understanding the role of lipid regulations' on cancer stem cell behavior. I am so grateful for the mentorship and supports of Wenjun @WenjunGuoLab. I also want to express my appreciation to all the co-authors. Thank you all.

[Wenjun_Guo @WenjunGuoLab]

How do lipids control cancer stem cells? In this @ScienceAdvances paper led by @Jihong_Cui, we found high levels of ABCA12 lipid transporter in breast CSCs reduce intracellular ceramide to activate the YAP/TAZ-SOX9 stemness program and chemoresistance. https://t.co/OtE8MGo73Y

[JIHONG @Jihong_Cui]

@dalessandrolab @WenjunGuoLab @ScienceAdvances Thanks for all the support!

[JIHONG @Jihong_Cui]

@FCendali Thanks for your contribution, Francesca.

[Mammary Cell News @MammaryCell]

🤯 The @WenjunGuoLab and collaborators showed that deletion of the epigenetic regulator MLL3, a tumor suppressor frequently altered in human cancer, promoted the acquisition of hybrid EMT in #BreastCancer cells! @Einstein_SCI @NIDDKgov

@NatureCellBio | https://t.co/p4M1CXPZ96

[Zhe Wang @ZheWang_NCB]

📢Latest @NatureCellBio: "MLL3 loss drives #metastasis by promoting a hybrid epithelial–mesenchymal transition state" by @Jihong_Cui @WenjunGuoLab et al from @Einstein_SCI @CDTMI_Einstein @EinsteinMed. #CancerResearch @NatResCancer
https://t.co/nwGISAh44J

[JIHONG @Jihong_Cui]

Great start of 2023. I am so happy to share our recent work @NatureCellBio . Many many thanks to @WenjunGuoLab. And thanks a lot to all co-authors. Can't make it without all of you.😊😊

[Wenjun_Guo @WenjunGuoLab]

Excited to share our latest work @NatureCellBio, identifying a role of MLL3/KMT2C mutations in allowing cancer cells to acquire highly metastatic hybrid EMT state. Spearheaded by @Jihong_Cui, great teamwork with Kai Ge, @zhengdy, @DanweiHuangfu groups. https://t.co/OsYpaCfgQA

[Wenjun_Guo @WenjunGuoLab]

Excited to share our latest work @NatureCellBio, identifying a role of MLL3/KMT2C mutations in allowing cancer cells to acquire highly metastatic hybrid EMT state. Spearheaded by @Jihong_Cui, great teamwork with Kai Ge, @zhengdy, @DanweiHuangfu groups. https://t.co/OsYpaCfgQA